Boston Scientific bolsters pulsed field ablation business with Cortex buy
As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the acquisition of an atrial fibrillation-focused startup. | Cortex’s FDA-cleared OptiMap system includes a basket-shaped catheter designed to fill the heart’s chambers with 64 electrodes.
An elevated heart rate could provide an important clue to which Black adults often have a dangerous heart rhythm disorder, a ...
What should you do with a patient whose Apple Watch reported a 2-hour episode of atrial fibrillation yesterday, but is in ...
Malone, who is running in the event for the first time, had a very scary moment after going into atrial fibrillation just a year ago.
Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...
After multiple medical procedures starting in May 2022, Arthur Schiebel was pleased to have his atrial fibrillation under control ... The trial uses an Apple smartwatch to monitor episodes of ...
The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...
Northwestern Medicine will be the first system to use Tempus' new algorithm to identify patients at risk for developing ...
Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...
Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback